Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.22.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]      
Revenue $ 0 $ 0 $ 37,000
Operating expenses:      
Research and development (10,712,000) (21,074,000) (90,774,000)
General and administrative (13,825,000) (11,052,000) (11,284,000)
Total operating expenses (24,537,000) (32,126,000) (102,058,000)
Operating loss (24,537,000) (32,126,000) (102,021,000)
Interest expense, net (5,553,000) (15,097,000) (861,000)
Financing transaction costs   (2,848,000)  
Adjustments to fair value of derivatives (60,964,000) (1,745,000)  
Extinguishment of debt   340,000  
Other income, net 195,000 213,000 196,000
Total other expense (66,322,000) (19,137,000) (665,000)
Loss before income taxes (90,859,000) (51,263,000) (102,686,000)
Income tax expense (705,000) (743,000) (444,000)
Net loss and comprehensive loss (91,564,000) (52,006,000) (103,130,000)
Net loss attributable to ordinary shareholders $ (91,564,000) $ (52,006,000) $ (103,130,000)
Net loss per share attributable to ordinary shareholders – basic and diluted $ (0.56) $ (2.17) $ (7.10)
Weighted average ordinary shares outstanding – basic and diluted 163,367,681 24,009,818 14,518,036